Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Rating) has been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Rating)’s stock price fell 4.4% during mid-day trading on Thursday . The company traded as low as $28.10 and last traded at $28.25. 249,544 shares were traded during mid-day trading, a decline of 52% from the average session volume of 517,368 shares. The stock had previously closed at $29.56. […]
Teacher Retirement System of Texas acquired a new stake in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Rating) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,015 shares of the company’s stock, valued at approximately $240,000. Other institutional […]